F5 Adds Gavin Munroe to its Board of Directors

F5 Adds Gavin Munroe to its Board of Directors

F5, Inc. (NASDAQ: FFIV), the global leader in delivering and securing every app and API, today announced the appointment of Gavin Munroe to its board of directors. Munroe's extensive experience as a technology leader in the financial services space makes him a valuable addition to F5's board. Mr. Munroe joined F5's board effective June 17, 2026 and will serve as a member of the board's Audit and Risk committees.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260623229226/en/

"Gavin has transformed some of the world's most complex global financial institutions, modernizing technology, building operational resilience, and pioneering AI enablement at enterprise scale, all while managing risk across highly regulated environments," said François Locoh-Donou, F5's Chairman, President, and CEO. "We are thrilled to welcome Gavin's expertise and his proven ability to deliver tangible outcomes, a perspective that will serve F5 well as we continue to grow."

Mr. Munroe most recently served as Chief Information Officer and Transformation Head at Commonwealth Bank of Australia, where he led technology modernization, AI enablement, data and analytics, and operational resiliency. He brings more than 25 years of technology leadership experience, having served in leading technology roles at some of the world's leading financial services firms.

With this appointment, F5's board expands to 10 members, 9 of whom are independent.

Gavin Munroe Background

Mr. Munroe most recently served as Chief Information Officer and Transformation Head at Commonwealth Bank of Australia. Prior to this, he served as Global Chief Information Officer at HSBC – Wealth, Private and Retail Banking. He has also held technology leadership roles at Bank of America/Merrill Lynch, Synechron, and Saxon (a division of Morgan Stanley). Mr. Munroe earned a Bachelor of Science degree in Computer Science from The University of Port Elizabeth.

About F5

F5, Inc. (NASDAQ: FFIV) is the global leader that delivers and secures every app. Backed by three decades of expertise, F5 has built the industry's premier platform—F5 Application Delivery and Security Platform (ADSP)—to deliver and secure every app, every API, anywhere: on-premises, in the cloud, at the edge, and across hybrid, multicloud environments. F5 is committed to innovating and partnering with the world's largest and most advanced organizations to deliver fast, available, and secure digital experiences. Together, we help each other thrive and bring a better digital world to life.

For more information visit f5.com

Explore F5 Labs threat research at f5.com/labs

Follow to learn more about F5, our partners, and technologies: Blog | LinkedIn | X | YouTube | Instagram | Facebook

F5 is a trademark, service mark, or tradename of F5, Inc., in the U.S. and other countries.

SOURCE: F5, Inc.

Media
Rob Gruening
(206) 272-6208
r.gruening@f5.com

Investors
Suzanne DuLong
(206) 272-7049
s.dulong@f5.com

News Provided by Business Wire via QuoteMedia

FFIV
The Conversation (0)
Sirona Biochem Announces Loan

Sirona Biochem Announces Loan

Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (" Sirona " or the " Company ") announced that it has entered into a demand grid promissory note (the " Note ") with 0906462 B.C. Ltd. (the " Lender ") for a loan in the aggregate principal amount of up to $1,000,000 (the " Loan ").... Keep Reading...
Sirona Biochem Initiates Private Placement

Sirona Biochem Initiates Private Placement

Sirona Biochem Corp. (TSX-V:SBM) (FSE: ZSB) (OTC: SRBCF) (the "Company") is pleased to announce a non-brokered private placement of up to 10,000,000 units of the Company at a price of $0.10 CAD per Unit (a "Unit") for gross proceeds of up to CAD$1,000,000 (the "Private Placement"). Each Unit... Keep Reading...
Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories

Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories

Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is proud to introduce Sirona Laboratories TM - a wholly-owned subsidiary dedicated to maximizing the commercial potential of its breakthrough anti-aging skincare ingredient, GlycoProteMim TM . Dr. Howard Verrico, CEO and founder of Sirona... Keep Reading...
The Stellantis Era Begins: Argentina Lithium  to drill up to 30 holes at Antofalla North Project

The Stellantis Era Begins: Argentina Lithium to drill up to 30 holes at Antofalla North Project

(TheNewswire) November 27, 2023 - TheNewswire - Global Stocks News - On November 20, 2023 Argentina Lithium (TSXV:LIT) (FSE:OAY3) (OTC:PNXLF) announced accelerated exploration plans for 2024 , following a $90 million (in ARS equivalent) financing agreement with Peugeot Citroen Argentina S.A., a... Keep Reading...
F5 Provides Cost and Performance Enhancing Technology in Support of Open Source Telemetry Project

F5 Provides Cost and Performance Enhancing Technology in Support of Open Source Telemetry Project

Code contribution improves protocol compression ratio by 2x and reduces bandwidth costs for high-volume telemetry initiatives and AI-driven projects F5 (NASDAQ: FFIV) today announced its continued support for Cloud Native Computing Foundation's OpenTelemetry , an open source framework providing... Keep Reading...

Interactive Chart

Latest Press Releases

Related News